Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Weight Loss 2Prostatic Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Obesity 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Diabetes Mellitus 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Diet, Carbohydrate-Restricted × Clear all
NCT02744079 2020-08-31

KetoBreast

Albert Einstein College of Medicine

Phase NA Completed
11 enrolled
Breast

Breast Neoplasms, Neoplasms

NCT01559194 2014-04-14

LEAF

Ohio State University Comprehensive Cancer Center

Phase 3 Completed
82 enrolled
Breast

Breast Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡